Decreased GAD65-specific Th1/Tc1 phenotype in children with Type 1 diabetes treated with GAD-alum

GAD65 Antigen Therapy in Recently Diagnosed Type 1 Diabetes Mellitus

(2012) Johnny Ludvigsson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial

(2011) Diane K Wherrett et al.   LANCET

Long-Lasting Immune Responses 4 Years after GAD-Alum Treatment in Children with Type 1 Diabetes

(2011) Stina Axelsson et al.   PLoS One

GAD-alum treatment in patients with type 1 diabetes and the subsequent effect on GADA IgG subclass distribution, GAD65 enzyme activity and humoral response

(2010) Mikael Chéramy et al.   CLINICAL IMMUNOLOGY

Early induction of GAD65-reactive Th2 response in type 1 diabetic children treated with alum-formulated GAD65

(2010) Stina Axelsson et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Impaired CD4+and CD8+T cell phenotype and reduced chemokine secretion in recent-onset type 1 diabetic children

(2008) M. Hedman et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

GAD Treatment and Insulin Secretion in Recent-Onset Type 1 Diabetes

(2008) Johnny Ludvigsson et al.   NEW ENGLAND JOURNAL OF MEDICINE